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Deprotection of S-Acetamidomethyl Cysteine with Copper (II) and 
1,2-Aminothiols under Aerobic Conditions 
Daishiro Kobayashi, Naoto Naruse, Masaya Denda, Akira Shigenaga,† and Akira Otaka* 
Ring-opening by CuSO4 of a 1,3-thiazolidine carbonyl structure (Thz) as an N-terminal cysteine (Cys) residue revealed that an 
intramolecular S–acetamidomethyl cysteine (Cys(Acm)) can also be deprotected with concomitant formation of a disulphide 
bond connecting the two Cys residues. A mechanistic study on the disulphide formation led to a general protocol for 
deprotection of the S-Acm group by CuSO4 and a 1,2-aminothiol under aerobic conditions. Application of this new 
deprotection reaction allowed for the synthesis of Apamin, a peptide with two-disulphides in a one-pot/stepwise disulphide-
bridging procedure.
Introduction 
Acetamidomethyl (Acm) protection1 of the sulphydryl group 
of cysteine has contributed significantly to the synthesis of 
cystine peptides including multiple disulphide-containing 
peptides.2 The S-Acm group remains intact under acidic 
conditions employed for deprotection of conventional side 
chain protecting groups, and its removal can be achieved by 
metal salts such as Hg(OCOCH3)21 or AgOTf3 to give cysteine 
peptides after treatment of the resulting S-metal peptides with 
thiols. Alternatively, oxidative conversion to a disulphide can be 
achieved by the action of I24, Tl(OCOCF3)35, chlorosilane-
sulphoxide6 or sulphenyl chloride systems7 (Figure 1). 
Figure 1. Deprotection of S-acetamidomethyl cysteine (Cys(Acm)). 
The unique chemical features of the S-Acm group support its 
widespread use in peptide/protein chemistry and the recent 
upward trend in native chemical ligation (NCL)8 reactions for  
protein chemical synthesis has led to new methods for Acm 
removal.9 In this context, we recently reported that a 1,3-
thiazolidine-4-carbonyl (Thz)10 residue as an N,S-protected 
cysteine derivative which is indispensable in NCL chemistry is 
deprotected by the action of CuSO4 to regenerate a cysteine 
residue.11 While evaluating the ring-opening of thiazolidine with 
CuSO4, we found that chemical behaviour of the S-Acm residue 
with CuSO4 is different when the Thz- and Cys(Acm)-containing 
peptide (Thz-GALYR-Cys(Acm)-FG-NH2 (1)) was treated with 
CuSO4 in the presence or absence of ascorbate. Under both 
conditions, ring-opening of the thiazolidine occurs but reaction 
with ascorbate followed by treatment with dithiothreithol (DTT) 
gave a thiazolidine-opened Cys(Acm) peptide (H-Cys(SH)-
GALYR-Cys(Acm)-FG-NH2 (2)), whereas reaction in the absence 
of ascorbate afforded an Acm-deprotected peptide (H-Cys(SH)-
GALYR-Cys(SH)-FG-NH2 (3))12,13. Additionally, replacement of 
DTT with EDTA affords intermolecular and intramolecular 
disulphide peptides 4 (Figure 2 and Figure S1 (Fig S1) in the SI). 
Figure 2. Ring-opening reactions of Thz with and without ascorbate. 
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1 Thz + 3a or 4b 
5 Ala – 5a 
2 Cys(SH) + 3a,c or 4b,c 
6 Ac-Cys(SH) – 6a 
aQuench with DTT; bQuench with EDTA; csmall amount of N-terminal cysteic acid 
peptide was detected (Fig S2). 
Results and Discussion 
To shed light on these unexpected results, we evaluated the 
chemical behaviour of the peptides in Table 1. Initially, direct 
involvement of the Cu salt in the removal of Acm group was 
examined using peptide 5 which has an Ala-substituent on the 
N-terminal Thz. Treatment of 5 with CuSO4 (40 eq.) in 6 M 
guanidine hydrochloride (Gn·HCl) in 3-[4-(2-hydroxyethyl)-
piperazin-1-yl]propane-1-sulphonic acid (HEPPS) buffer at pH 
7.0 did not affect the Acm group and led to recovery of the 
starting material, indicating that the Thz or regenerated Cys 
residue is involved in the Cu-induced removal of the Acm group. 
The N-terminal cysteine peptide 2 was subjected to the Cu-
mediated reaction followed by DTT quenching to afford 3. On 
the other hand, removal of Acm group did not occur in the 
reaction of N-acetyl Cys peptide 6 and reaction of 1 or 2 with 
CuSO4 followed by quenching with EDTA gave disulphide 
peptides which could be intra- or intermolecularly paired.  
 
Figure 3. Plausible mechanism for the deprotection of Acm and the formation of 
disulphide peptide under Cu(II) conditions. 
 









(%)), 5 (remaining (%))c 
1 9a (25) 100 A 11a (41)d, 5 (59) 
2 9a (50) 100 A 11a (73)d, 5 (27) 
3 9a (100) 100 A 11a (> 95), 5 (ND) 
4 9a (100) 100 B 12 (78)e 
5 9a (200) 100 A 11a (18), 5 (82) 
6 9a (300) 100 A 11a (5), 5 (95) 
7 9a (25) 25 A 11a (71), 5 (29) 
8 9a (50) 50 A 11a (98)d, 5 (2) 
9f 9a (100) 100 A 11a (59), 5 (41) 
10 9b (100) 100 A 11b (40), 5 (60) 
11 9c (100) 100 A 11c (66), 5 (34) 
aReactions were conducted at 37 °C, pH 5 under ambient atmospheric conditions for 3 
h; bQuench method: (A) Addition of 100 mM EDTA aq. (B) Addition of 500 mM DTT and 
500 mM ascorbate followed by stirring at 37 °C for 30 min; cConversion (%) (or remaining 
(%)) proportions were determined by HPLC analysis with UV detection at 220 nm and 
calculated using the equation percent formation = 100 [(integ. 5 or 11 or 12)/(integ. 5 + 
integ. 11 + integ. 12)]: integ. = integration of peak area of the UV absorption; dNot 
separable, but small amount of the disulphide form of 12 was a contaminant in the 
eluted 11a on HPLC analysis; eIsolated yield; fUnder inert atmospheric conditions (Fig S3 
in the SI). 
From these results, we speculated that an N-terminal Cys 
residue as a 1,2-aminothiol moiety would be converted to an 
oxidizing species and function as an Acm deprotecting agent 
affording the disulphide. In contrast, reaction in the presence of 
ascorbate probably does not involve the formation of such an 
oxidizing species with the Acm group remaining intact. 
Generally, compared to an internal Cys residue, an N-terminal 
Cys is known to be easily oxidized14 in the presence of metal 
salts producing the disulphide via formation of oxidizing species 
such as sulphenic acid. Although other possibilities cannot be 
eliminated, a possible explanation for the outcome of the 
reaction in the absence of ascorbate is that an N-terminal 
sulphenic acid moiety is formed by the action of Cu(II) and 
subsequent nucleophilic attack of the sulphur atom of S-Acm 
occurs and is followed by disulphide formation, as shown in 
Figure 3. This envisioned us that the reaction of a Cys(Acm)-
containing peptide with CuSO4 in the presence of 1,2-
aminothiols such as cysteamine would allow for the oxidative 
removal of Acm group. We attempted to remove the Acm group 
by reagent mixtures with varying CuSO4/cysteamine ratios as 
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shown in Table 2, where stoichiometry of the reagents was also 
changed. Use of excess cysteamine relative to copper ions 
prevented the deprotection from reaching completion (entries 
3 vs 5 and 6). On the other hand, the reaction tolerated the 
excess amount of the copper ion relative to cysteamine. (entries 
3 vs 1 and 2). A possible explanation for incomplete 
deprotection under conditions shown in entries 5 and 6 is that 
the use of excess cysteamine relative to CuSO4 led to the 
formation of an insoluble white precipitate probably consisting 
of copper and cysteamine. A large excess amount of the mixture 
consisting of CuSO4/cysteamine (1:1) achieved the quantitative 
conversion of 5 to the corresponding hetero disulphide dimer 
11a (entries 3 vs 7 and 8). Reaction of 5 (1 mM) with 
CuSO4/cysteamine (1:1, 100 mM) in 6 M Gn·HCl–0.1 M HEPPS 
under an ambient atmosphere proceeded quantitatively in 3 h 
at 37 °C forming a pale yellow clear solution  and giving 11a in 
>95% conversion judged by HPLC analysis and the Cys-form 12 
in 78% isolated yield after reduction with DTT in the presence 
of ascorbate (entry 4). Reaction under an inert atmosphere 
decreased the conversion rate to about 60%, which indicates 
that oxygen is involved in the oxidative conversion of S-Acm to 
disulphides (entry 9). From these results, a plausible mechanism 
can be envisioned and is shown in Figure 4. The thiol group of 
cysteamine could form an intramolecular hydrogen bond or 
zwitterion with the amino group and dissociating into a thiolate 
anion which is more easily oxidized than a thiol to an oxidizing 
species such as sulphenic acid with participation of the 
neighbouring amine. Electrophilic attack of the resulting 
sulphenic acid on the sulphide of Cys(Acm) followed by release 
of an acetoamidomethyl cation gives the hetero disulphide. This 
envisioned mechanism involving an electrophilic sulphenic acid 
moiety would be essentially identical to those of oxidative 
deprotection procedures including I2-, sulphenyl chloride- and 
sulphoxide–chlorosilane-mediated systems.  
Next, the capability of other thiols to deprotect of Acm group 
was evaluated. The cysteine–CuSO4 system was not effective for 
the deprotection probably due to preferential formation of the 
zwitterionic carboxylate anion and ammonium cation in the 
cysteine molecule (entry 10).  
 
Figure 4. Plausible mechanism for the deprotection of Acm under Cu(II) and cysteamine 
conditions. 
 
Table 3. Examination of deprotection of other S-protecting groupsa 
 
Entry S-Protecting group 
12 (Conversion (%)), 13 or 14 
(remaining (%)) 
1 Trt 12 (>95), 13 (ND) 
2 MBzl 12 (25)b, 14 (75) 
aConversion (%) (or remaining (%)) were determined by HPLC analysis with UV detection 
at 220 nm and calculated using the equation, percent formation = 100[(integ. 12 or 13 
or 14)/(integ. 12 + 13 or 12 + 14)]: integ. = integration of peak area of the UV absorption; 
bA small amount of sulphoxide of 14 was detected (Fig S4 in the SI). 
A cysteine amide could be used as an alternative to cysteamine 
for the oxidative removal of Acm group, but in this case the 
removal was incomplete after 3 h reaction (entry 11).  
Other S-protecting groups were subjected to the cysteamine–
CuSO4 system. N-Terminal alaninyl peptides containing S-
triphenylmethyl cysteine (Cys(Trt)) or S-p-methoxybenzyl 
cysteine (Cys(MBzl)) (H-Ala-GALYR-Cys(Trt)-FG-NH2 (13) or H-
Ala-GALYR-Cys(MBzl)-FG-NH2 (14)), respectively (Table 3) were 
examined. Quantitative removal of S-Trt group with CuSO4–
cysteamine was observed but deprotection of S-MBzl group 
remained incomplete. Such difference is probably attributable 
to the ease of formation of cations derived from S-Trt, S-MBzl 
or S-Acm. Reaction of Met-containing peptide with CuSO4–
cysteamine gave a small amount of sulphoxide and 
uncharacterized peptides (Fig S5 in the SI). In the suggested 
reaction mechanism, CuSO4 participates in the oxidative 
removal of Acm through formation of a sulphenic acid species. 
Other metals can be involved in Acm removal in the presence of 
1,2-aminothiols. The use for example of potassium ferricyanide, 
K3[Fe(CN)6]–cysteamine allows for the oxidative removal of the 
Acm group of peptide 2 but the reaction proceeded more slowly 
than reactions using CuSO4 (Fig S6 in the SI). We next attempted 
to treat peptide 2 with H2O2 to disclose whether CuSO4 
functions as a generator of hydroxy radicals or as Lewis acid to 
accelerate the oxidation of the 1,2-aminothiol moiety. 
Attempted reaction afforded the disulphide dimer of 2 as a 
main product with accompanying negligible amount of the Acm-
deprotected peptide 4 (Fig S7 in the SI).   
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Figure 5. Examination of the CuSO4–cysteamine system to establish the second 
disulphide bridge (Cys1–Cys11) of Apamin. 
 
Figure 6. HPLC data from the one-pot/sequential disulphide-bridging in the synthesis of 
Apamin. (A) Air oxidation: t = 24 h; (B) Addition of CuSO4: t = 5 h. Analytical HPLC 
conditions: linear gradient of 0.1% TFA/CH3CN in 0.1% TFA/H2O, 5% to 40% over 30 min. 
*N-Terminal cysteic acid peptide. 
Subsequently, the CuSO4–cysteamine system was applied to the 
synthesis of the bis-disulphide-bridging peptide, Apamin 15 as 
shown in Figures 5, 6, Figs S8 and S9 in the SI).  Because Apamin 
has two disulphide bridges (Cys1–Cys11 and Cys3–Cys15), linear 
peptides are required for stepwise disulphide bond formation, 
and Thz1-N-Cys(SH)3-KAPETAL-Cys(Acm)11-ARR-Cys(SH)15-
QQH-NH2 (16), was initially prepared by an Fmoc-based solid-
phase peptide protocol. 1,3-Thiazolidine carbonyl (Thz), 
triphenyl methyl-S-cysteine (Cys(Trt)) and Cys(Acm) were 
employed as protecting groups for cysteines at positions 1, 3 
and 15, and 11. Protected peptide resin was treated with TFA to 
afford the linear peptide 16, which was subjected to an air-
oxidation step (0.5 mM peptide concentration) in 6 M Gn·HCl–
0.1 M HEPPS buffer (pH 7.7) at 37 °C for 24 h to establish the 
first disulphide bond between Cys3 and Cys15. Then, a solution 
of CuSO4 was added to the reaction mixture containing one-
disulphide pairing peptide 17 to construct the second disulphide 
bond, between Thz1 and Cys(Acm)11. The attempted CuSO4-
mediated reaction readily afforded the desired Cys1–Cys15 
disulphide-linked peptide 15 in 61% isolated yield after EDTA 
quenching although small amounts of oxidative side products 
were also detected (Figure 6). Disulphide pairs of synthetic 15 
was confirmed by comparative HPLC analyses of 15 and possible 
three isomers prepared by a regioselective disulphide-forming 
reaction15(Fig S8 in the SI). Next, we conducted the disulphide-
bridging in reverse order using Thz1-N-Cys(MBzl)3-KAPETAL-
Cys(Acm)11-ARR-Cys(MBzl)15-QQH-NH2 (18) (Fig S9 in the SI).  
However, attempts to construct the disulphide bond between 
Thz1 and Cys(Acm)11 with CuSO4 under aerobic conditions 
resulted in the formation of significant amounts of Cys1-over-
oxidized peptides. The reason for this difference in the CuSO4-
mediated oxidation steps might be attributable to the 
possibility that the initially formed disulphide bond of peptide 
16 facilitates the second step disulphide-bridging with CuSO4. 
Conclusions 
Studies on the ring-opening of the Thz residue in a Cys(Acm)-
containing peptide with CuSO4 under aerobic conditions led to 
the finding that formation of an intramolecular disulphide bond 
between the Thz and Cys(Acm) residues occurs. Experimental 
examination of the reason for the disulphide formation 
revealed the pivotal role of the Thz-derived thiol which is 
susceptible to Cu(II)-mediated oxidation under the influence of 
the neighbouring amino group. Consequently, such insights 
resulted in both the development of an S-Acm deprotection 
system mediated by CuSO4–1,2-aminothiols under aerobic 
conditions and the synthesis of Apamin, a peptide containing 
two disulphides in a one-pot/sequential disulphide-bridging 
reaction. Finally, the development of a more sophisticated 
deprotection format for S-Acm groups from the CuSO4–1,2-




 Materials.  All reagents and solvents were obtained from the 
Peptide Institute, Inc. (Osaka, Japan), FUJIFILM Wako Pure Chemical 
Corporation (Osaka, Japan), Tokyo Chemical Industry Co., Ltd (Tokyo, 
Japan), Nacalai Tesque, Inc. (Kyoto, Japan), Watanabe Chemical 
Industries, Ltd (Hiroshima, Japan), Merck KGaA (Darmstadt, 
Germany) and Sigma-Aldrich Co. LLC (St Louis, MO).  
HPLC, MS. Each peptide was characterized by MS analysis as 
described below. Mass spectra were recorded on a LC-MS (Shimadzu, 
Japan, Prominence-I LC-2030, LCMS-2020) and a Cosmosil 5C18-AR-II 
analytical column (Nacalai Tesque, Japan, 4.6 × 250 mm, flow rate 
1 mL min-1, were used, and eluting products were detected by UV at 
220 nm and MS). For HPLC separation, HPLC was carried out on 
HITACHI L-7150 with an L-2400 detector using a Cosmosil 5C18-AR-II 
analytical column (Nacalai Tesque, 4.6 × 250 mm, flow rate 1.0 mL 
min-1), a Cosmosil 5C18-AR-II semipreparative column (Nacalai 
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Tesque, 10 × 250 mm, flow rate 3.0 mL min-1), or a Cosmosil 5C18-AR-
II preparative column (Nacalai Tesque, 20 × 250 mm, flow rate 10 mL 
min-1) eluting with a linear gradient system (solvent A: 0.1% TFA in 
H2O, solvent B: 0.1% TFA in CH3CN) 
SPPS. Unless otherwise stated, peptides used in this work 
were synthesized by Fmoc solid-phase peptide synthesis (Fmoc-
SPPS) on Rink Amide AM resin (0.67 mmol g-1) or Histidine 2-
chlorotrityl resin (0.29 mmol g-1). Fmoc SPPS was performed 
according to the following protocol. 1) Removal of Fmoc groups 
was carried out with 20% piperidine/DMF for 10 min at room 
temperature (RT). 2) The resin was washed with DMF (× 5). 3) A 
standard Fmoc-protected amino acid (4.0 equiv.) was coupled 
with the aid of N,N-diisopropylcarbodiimide (DIPCI) (4.0 equiv.) 
and 1-hydroxy-benzotriazole monohydrate (HOBt·H2O) (4.0 
equiv.) in DMF for 1.5 h at RT. Completion of the coupling 
reaction was confirmed by the Kaiser ninhydrin test. The 
coupling reaction was repeated until the Kaiser test became 
negative. 4) The resin was washed with DMF (× 3). A cycle of 
step 1 to 4 was repeated. Deprotection of acid-labile protecting 
groups with concomitant release of peptides from a resin was 
achieved using a cocktail of TFA/TES/H2O (v/v, 95/2.5/2.5) (50 
μL/1 mg resin) at RT for 1.5–2 h. After the resin was filtered off, 
cooled Et2O was added to the filtrate and the precipitate was 
collected by centrifugation. The obtained precipitate was 
washed with cooled Et2O and purified by preparative HPLC. The 
following side-chain protected amino acids were employed: 
Arg(Pbf), Asp(OtBu), Cys(Acm), Cys(MBzl), Cys(tBu), Cys(Trt), 
Glu(OtBu), His(Trt), Lys(Boc), Ser(tBu), Thr(tBu), Tyr(tBu). 
 
Synthesis of peptides 
H-Thz-GALYR-Cys(Acm)-FG-NH2 (1) (16.4 mg, 12.6 mol, 38% 
isolated yield): Analytical HPLC conditions: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 19.5 min. 
Preparative HPLC conditions: linear gradient of solvent B in 
solvent A, 14% to 24% over 30 min,  tR = 16.1 min. LRMS (M + H) 
calcd for C47H70N14O11S2 1071.5, found 1071.2. 
H-Cys-GALYR-Cys(Acm)-FG-NH2 (2) (5.8 mg, 4.5 mol, 27% 
isolated yield): Analytical HPLC conditions: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 19.2 min. 
Preparative HPLC conditions: linear gradient of solvent B in 
solvent A, 15% to 25% over 30 min, tR = 13.8 min. LRMS (M + H) 
calcd for C46H70N14O11S2 1059.5, found 1059.3. 
H-Ala-GALYR-Cys(Acm)-FG-NH2 (5) (13.7 mg, 10.9 mol, 33% 
isolated yield): Analytical HPLC conditions: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 18.6 min. 
Preparative HPLC conditions: linear gradient of solvent B in 
solvent A, 14% to 24% over 30 min, tR = 13.9 min. LRMS (M + H) 
calcd for C46H70N14O11S 1027.5, found 1027.2. 
Ac-Cys-GALYR-Cys(Acm)-FG-NH2 (6) (11.4 mg, 9.4 mol, 56% 
isolated yield): Analytical HPLC conditions: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 22.9 min. 
Preparative HPLC conditions: linear gradient of solvent B in 
solvent A, 18% to 28% over 30 min, tR = 17.1 min. LRMS (M + H) 
calcd for C48H72N14O12S2 1101.5, found 1101.6. 
H-Ala-GALYR-Cys-FG-NH2 (12) (8.6 mg, 7.3 mol, 26% isolated 
yield): Analytical HPLC conditions: linear gradient of solvent B in 
solvent A, 5% to 45% over 30 min, tR = 19.7 min. Preparative 
HPLC conditions: linear gradient of solvent B in solvent A, 16% 
to 26% over 30 min, tR =   14.7 min. LRMS (M + H) calcd for 
C43H65N13O10S 956.5, found 956.5. 
H-Ala-GALYR-Cys(MBzl)-FG-NH2 (14) (1.7 mg, 1.3 mol, 14% 
isolated yield): Analytical HPLC conditions: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 25.1 min. 
Preparative HPLC conditions: linear gradient of solvent B in 
solvent A, 23% to 33% over 30 min, tR = 15.6 min. LRMS (M + H) 
calcd for C51H73N13O11S 1076.5, found 1076.5. 
H-Ala-GALYR-Met-FG-NH2 (S1) (8.7 mg, 7.1 mol, 21% isolated 
yield): Analytical HPLC conditions: linear gradient of solvent B in 
solvent A, 5% to 45% over 30 min, tR = 23.6 min. Preparative 
HPLC conditions: linear gradient of solvent B in solvent A, 22% 
to 32% over 30 min, tR = 10.2 min. LRMS (M + H) calcd for 
C51H73N13O11S 984.5, found 984.1. 
Ratio of CuSO4 and ascorbate 
An aqueous solution of CuSO4 (2.5 L of 0.8 M; final 
concentration 40 mM) was added to a solution of 1 (1 mM, 50 
L) in 6 M Gn·HCl in 0.1 M HEPPS (pH 7.0) in the presence of Na 
ascorbate solution (2.5 l of 0.8 M,  1.6 M or 2.4 M; final 
concentration 40 mM, 80 mM or 120 mM, respectively) or in 
the absence of ascorbate. The reaction was continued for 1 h at 
37 °C and pH 5 under ambient atmosphere. To quench the 
reaction, 100 mM EDTA aq. or solid DTT was added to the 
reaction. After filtering off the precipitate, the resulting solution 
was analyzed by HPLC. 
Analytical HPLC conditions of peptide 2: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 18.9 min. 
LRMS (M + H) calcd for C46H70N14O11S2 1059.5, found 1059.7. 
Analytical HPLC conditions of peptide 3: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 20.4 min. 
LRMS (M + H) calcd for C43H65N13O11S2 988.5, found 988.6. 
Analytical HPLC conditions of peptide 4: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 18.8 min. 
LRMS (M + H) calcd for C43H63N13O10S2 986.4, found 986.6. 
Evaluation of the contribution of the N-terminal amino acid 
to the deprotection of Acm group 
CuSO4 solution (2.5 L of 0.8 M; final concentration 40 mM) was 
added to a solution of 1, 2, 5 or 6 (1 mM, 50 L) in 6 M Gn·HCl 
in 0.1 M HEPPS (pH 7.0). The reaction was continued for 1 h at 
37 °C and pH 5 under ambient atmosphere. To quench the 
reaction, 100 mM EDTA aq. was added to the reaction. After 
filtering off the precipitate, the resulting solution was analyzed 
by HPLC. 
Analytical HPLC conditions of peptide 4: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 18.7 min. 
LRMS (M + H) calcd for C43H63N13O10S2 986.4, found 986.5. 
Optimization of conditions for removal of Acm group  
Peptide 5 (1 mM, 50 L) was treated with various 
concentrations of CuSO4 (2.5 L of 0.50 M, 1.0 M or 2.0 M; final 
concentrations 25 mM, 50 mM or 100 mM, respectively) in 6 M 
Gn·HCl–0.1 M HEPPS buffer (pH 7.0) in the presence of 1,2-
aminothiols (9a, 9b or 9c at the concentrations shown in Table 
2) and ethyl 4-hydroxybenzoate as internal standard. The 
reaction mixture was stirred for 3 h at 37 °C, pH 5 under ambient 
atmosphere and quenched with 100 mM EDTA aq. or 500 mM 
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ascorbate (solid form) and 500 mM DTT (solid form) followed by 
stirring for 30 min. Then, progress of reaction was monitored by 
HPLC analyses. 
Analytical HPLC conditions of peptide 11a: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 27.6 min. 
LRMS (M + H) calcd for C45H70N14O10S2 1031.5, found 1031.4. 
Analytical HPLC conditions of peptide 11b: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 27.6 min. 
LRMS (M + H) calcd for C46H70N14O12S2 1075.5, found 1075.4. 
Analytical HPLC conditions of peptide 11c: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 27.6 min. 
LRMS (M + H) calcd for C46H71N15O11S2 1074.5, found 1074.6. 
Analytical HPLC conditions of peptide 12: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 19.5 min. 
LRMS (M + H) calcd for C43H65N13O10S 956.5, found 956.5. 
Synthesis of Peptide Containing Cys(Trt)16 
Trt-OH (1.0 mg, 4.0 mol) was added to a solution of Peptide 12 
(2.3 mg, 2.0 mol) in HFIP (400 L). The reaction mixture was 
stirred at RT for 6 h. Then, the solution was concentrated by N2 
gas, and the resulting crude material was purified by 
preparative HPLC. 
 H-Ala-GALYR-Cys(Trt)-FG-NH2 (13) (1.0 mg, 0.70 mol, 35% 
isolated yield): Analytical HPLC conditions: linear gradient of 
solvent B in solvent A, 5% to 95% over 30 min, tR = 17.5 min. 
Preparative HPLC conditions: linear gradient of solvent B in 
solvent A, 36% to 46% over 30 min, tR = 12.4 min. LRMS (M + H) 
calcd for C62H79N13O10S 1198.6, found 1198.5. 
Evaluation of the stability of other S-protecting group in the 
presence of CuSO4 and cysteamine 
CuSO4 solution (2.5 L of 2.0 M; final concentration 100 mM) 
was added to a solution of 13 or 14 (1 mM, 50 L) in 6 M Gn·HCl 
in 0.1 M HEPPS (pH 7.0) in the presence of cysteamine 
derivatives (100 mM). The reaction was continued for 3 h at 
37 °C and pH 5 under ambient atmosphere. After quenched 
with 100 mM EDTA aq., the resulting solution was filtered and 
then analyzed by HPLC.  
Treatment of Met-containing peptide with CuSO4 in the presence 
or absence of cysteamine 
CuSO4 solution (2.5 L of 2.0 M or 800 mM; final concentration 
100 mM or 40 mM) was added to a solution of S1 (1 mM, 50 L) 
in 6 M Gn·HCl in 0.1 M HEPPS (pH 7.0) in the presence or 
absence of cysteamine (100 mM). The reaction was continued 
for 3 h or 45 min at 37 °C and pH 5 under ambient atmosphere. 
After quenched with 100 mM EDTA aq., the resulting solution 
was filtered and then analyzed by HPLC. 
Analytical HPLC conditions of peptide S2: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 18.8 min. 
LRMS (M + H) calcd for C45H69N13O11S 1000.5, found 1000.1. 
Analytical HPLC conditions of peptide S3: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 24.0 min. 
LRMS (M + H) calcd for C47H74N14O11S2 1075.5, found 1075.0. 
Examination of deprotection of Acm mediated by iron salts 
A K3FeCN6 solution (2.5 L of 2.0 M; final concentration 100 
mM) was added to a solution of 2 (1 mM, 50 L) in 6 M Gn·HCl 
in 0.1 M HEPPS (pH 7.0) in the presence of cysteamine (100 mM). 
The reaction was continued for 3 h at 37 °C and pH 5 under 
ambient atmosphere. After quenched with 100 mM EDTA aq., 
the resulting solution was filtered and then analyzed by HPLC. 
Examination of deprotection of S-Acm with H2O2 
H2O2 solution (2.5 L of 0.8 M; final concentration 40 mM) was 
added to a solution of 2 (1 mM, 50 L) in 6 M Gn·HCl in 0.1 M 
HEPPS (pH 7.0). The reaction was continued for 45 min at 37 °C 
and pH 5 under ambient atmosphere. After filtering off the 
precipitate, the resulting solution was analyzed by HPLC. 
Analytical HPLC conditions of peptide 4: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 20.4 min. 
LRMS (M + H) calcd for C43H63N13O10S2 986.4, found 986.1. 
Analytical HPLC conditions of peptide S4: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 20.4 min. 
LRMS (M + H) calcd for C43H63N13O10S2 1107.5, found 1107.0. 
Analytical HPLC conditions of the dimer of peptide 2: linear 
gradient of solvent B in solvent A, 5% to 45% over 30 min, tR = 
22.6 min. LRMS (M + 2H) calcd for C92H138N28O22S4 1058.5, found 
1058.5. 
Analytical HPLC conditions of peptide S5: linear gradient of 
solvent B in solvent A, 5% to 45% over 30 min, tR = 21.9 min. 
LRMS (M + 2H) calcd for C92H138N28O23S4 1066.5, found 1066.0. 
Application of the CuSO4–cysteamine system to establish the 
second disulphide bridge (Cys1-Cys11) of Apamin 
H-Thz-N-Cys-KAPETAL-Cys(Acm)-ARR-Cys-QQH-OH (16) The 
peptide was assembled on the Fmoc-His(Trt)-2-Cl-Trt resin 
(0.010 mmol) using the SPPS procedure as described above. The 
subsequent deprotection of the resin was carried out with 
TFA/TES/H2O (v/v/v, 95/2.5/2.5) for 2 h to give a crude product, 
which was purified by preparative HPLC to yield the title 
compound (7.9 mg, 3.1 mol, 31% isolated yield): Analytical 
HPLC conditions: linear gradient of solvent B in solvent A, 5% to 
45% over 30 min, tR = 13.9 min. Preparative HPLC conditions: 
linear gradient of solvent B in solvent A, 16% to 26% over 30 min, 
tR  = 20.8 min. LRMS (M + 2H) calcd for C83H139N31O26S4 1058.0, 
found 1058.2. 
To establish the first disulphide bridge, a solution of 16 (0.5 mM, 
2 mL) in 6 M Gn·HCl in 0.1 M HEPPS (pH 7.7) was stirred for 24 
h at 37 °C under the ambient atmosphere. After completion of 
formation of the first disulphide bridge, CuSO4 solution (100 μl 
of 2.0 M; final concentration 100 mM) was added to the 
reaction mixture with additional stirring for 5 h at 37 °C. The 
reaction was quenched by the addition of 100 mM EDTA aq. to 
the mixture. After filtering off the precipitate, HPLC purification 
of the filtrate gave Apamin 15 in 61% (1.6 mg) isolated yield. 
Analytical HPLC conditions of peptide 17: linear gradient of 
solvent B in solvent A, 5% to 40% over 30 min, tR = 15.6 min. 
LRMS (M + 2H) calcd for C83H137N31O26S4 1057.0, found 1057.1. 
Analytical HPLC conditions of Apamin 15: linear gradient of 
solvent B in solvent A, 5% to 40% over 30 min, tR = 13.3 min. 
LRMS (M + 2H) calcd for C79H130N30O25S4 1014.4, found 1014.7. 
Synthesis of disulphide isomers using regioselective disulphide-
forming reaction15  
Syntheses of isomers were conducted by the regioselective 
disulphide-forming reaction consisting of air-oxidation and 
subsequent I2 treatment. Requisite peptides (Cys(SH)1, Cys(Acm)3, 
Cys(SH)11 and Cys(Acm)15-peptide, Cys(SH)1, Cys(Acm)3, 
Cys(Acm)11 and Cys(SH)15-peptide and Cys(SH)1, Cys(SH)3, 
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Cys(Acm)11 and Cys(Acm)15-peptide were synthesized by Fmoc-
SPPS protocol using Cys(Trt) and Cys(Acm) as S-protected cysteine 
derivatives. Linear Cys(Acm) peptides were subjected to air-
oxidation process to establish the first disulphide bond. After being 
purified by HPLC purification, mono-disulphide peptides were 
treated with I2 in MeOH/0.5 M HCl aq. (4/1) to construct the second 
disulphide bond. The reactions were quenched by the addition of 
ascorbate until the reaction mixture becomes colorless. Then, the 
mixture was purified by preparative HPLC.  
Cys1–Cys11 and Cys3–Cys15 isomer (Apamin): linear gradient of 
solvent B in solvent A, 5% to 40% over 30 min, tR = 15.0 min. 
Cys1–Cys15 and Cys3–Cys11 isomer: linear gradient of solvent B in 
solvent A, 5% to 40% over 30 min, tR = 16.3 min. 
Cys1–Cys3 and Cys11–Cys15 isomer: linear gradient of solvent B in 
solvent A, 5% to 40% over 30 min, tR = 16.2 min. 
Examination of the use of CuSO4–cysteamine system to establish 
the first disulphide bridge (Cys1-Cys11) of Apamin  
The peptide H-Thz-N-Cys(MBzl)-KAPETAL-Cys(Acm)-ARR-
Cys(MBzl)-QQH-OH (18) was assembled on the Fmoc-His(Trt)-2- 
Cl-Trt resin (0.010 mmol) using the SPPS procedure as described 
above. Subsequent deprotection of the resin was carried out 
with TFA/TES/H2O (v/v/v, 95/2.5/2.5) for 2 h to give a crude 
product, which was purified by preparative HPLC to yield the 
title compound (5.2 mg, 1.9 mol, 18% isolated yield): 
Analytical HPLC conditions: linear gradient of solvent B in 
solvent A, 5% to 45% over 30 min, tR = 19.9 min. Preparative 
HPLC conditions: linear gradient of solvent B in solvent A, 16% 
to 26% over 30 min, tR = 15.1 min. LRMS (M + 2H) calcd for 
C99H155N31O28S4 1178.0, found 1178.4. 
CuSO4 solution (2.5 L of 2.0 M; final concentration 100 mM) 
was added to a solution of 18 (1 mM, 50 L) in 6 M Gn·HCl in 
0.1 M HEPPS (pH 7.0). The reaction was continued for 1 h at 
37 °C and pH 5 under ambient atmosphere. After quenched 
with 100 mM EDTA aq., the resulting solution was filtered and 
then analyzed by HPLC. 
Analytical HPLC conditions of peptide 19: linear gradient of 
solvent B in solvent A, 5% to 40% over 30 min, tR = 21.0 min. 
LRMS (M + 3H) calcd for C95H148N30O27S4 757.3, found 757.4. 
Examination of deprotection of S-Acm in de-aerated solvent. 
CuSO4 solution (2.5 L of 2.0 M; final concentration 100 mM) 
was added to a de-aerated solution of 5 (1 mM, 50 L) in 6 M 
Gn·HCl in 0.1 M HEPPS (pH 7.0) in the presence of cysteamine 
(100 mM). The reaction was continued for 3 h at 37 °C and pH 5 
under an Ar atmosphere. After quenched with 100 mM EDTA 
aq., the resulting solution was filtered and then analyzed by 
HPLC.  
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